Hard to figure out what is really happening with premiums for health insurance purchased on the reform law exchanges.
Read More
Today, we hear from the PBM trade association, pointing (or giving) the finger at medication makers for high prices.
Read More
In the frenzy over drug prices, all sides are releasing studies on who is to blame. Here is one sponsored by the drug manufacturers' trade association.
Read More
CMS released the third annual evaluation of the Maryland all-payer, global budget reimbursement system.
Read More
An interesting study in the New England Journal of Medicine finds that removal of incentives relating to quality of care measures decreases performance.
Read More
Seems obvious, but a Health Affairs study confirms that premiums on the insurance exchanges are higher when fewer plans participate.
Read More
Here is a shock, a government program, Medicare, that wastes taxpayer dollars by paying more for care in one setting than another, in this case long-term care hospitals.
Read More
CMS issues the first annual outside evaluation of the Next Generation ACO program, finding some modest savings.
Read More
A study carried in Health Affairs discusses trends in high-deductible health plans.
Read More
The Alliance for Regenerative Medicine releases a sponsored study of the cost-effectiveness analysis of new cell and gene therapies.
Read More
Hospitals post underwhelming purchasing savings following acquisition activity, according to a new paper at NBER.
Read More
An analysis published in JAMA finds that Medicare is wasting about a billion dollars a year purchasing brand-name drugs.
Read More
An analysis in Health Affairs compares hospital, home health and SNF use and variation in Medicare Advantage versus the fee-for-service version.
Read More
A report from the Minnesota Department of Health reveals the variation in hospital pricing.
Read More